FDA letter monthly archive

FDA Letters in November 2016

Name: FDA Letters in November 2016
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued or posted in November 2016. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Ferring Pharmaceuticals, Inc. (Nov 23, 2016)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Safety and adverse events, Clinical efficacy and substantial evidence, Device constituent and human factors. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedNov 23, 2016
US FDA• MILPROSA

Complete Response Letter Ferring Pharmaceuticals, Inc. (Nov 23, 2016)